Literature DB >> 23703400

[No causal relationship between human papillomavirus and nasopharyngeal carcinoma].

G Psychogios1, J Zenk.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23703400     DOI： 10.1007/s00066-013-0338-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

2.  High-risk human papillomavirus in nasopharyngeal carcinoma.

Authors:  Aatur D Singhi; Joseph Califano; William H Westra
Journal:  Head Neck       Date:  2011-04-11       Impact factor: 3.147

3.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

4.  HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans.

Authors:  Jessica H Maxwell; Bhavna Kumar; Felix Y Feng; Jonathan B McHugh; Kitrina G Cordell; Avraham Eisbruch; Francis P Worden; Gregory T Wolf; Mark E Prince; Jeffrey S Moyer; Theodoros N Teknos; Douglas B Chepeha; Jay Stoerker; Heather Walline; Thomas E Carey; Carol R Bradford
Journal:  Head Neck       Date:  2010-05       Impact factor: 3.147

5.  Prognostic factors in limited (T1-2, N0-1) oropharyngeal carcinoma treated with surgery ± adjuvant therapy.

Authors:  Georgios Psychogios; Konstantinos Mantsopoulos; Abbas Agaimy; Michael Koch; Johannes Zenk; Frank Waldfahrer; Heinrich Iro
Journal:  Head Neck       Date:  2013-03-06       Impact factor: 3.147
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.